Teza Capital Management LLC Pacira Bio Sciences, Inc. Transaction History
Teza Capital Management LLC
- $809 Million
- Q2 2024
A detailed history of Teza Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 13,214 shares of PCRX stock, worth $218,295. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,214
Previous 18,955
30.29%
Holding current value
$218,295
Previous $553,000
31.65%
% of portfolio
0.05%
Previous 0.07%
Shares
11 transactions
Others Institutions Holding PCRX
# of Institutions
302Shares Held
51.6MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$132 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$84 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$35.7 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$34.1 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$31.5 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $757M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...